Whether you’ve travelled to Washington DC to enjoy the 22nd American Society of Gene & Cell Therapy (ASGCT) Annual Meeting or not, we’ve got you covered, with daily video updates and more!
Today's top abstracts
- ‘Standard’ production platforms can provide viral vector variance
- Retinal pigment epithelial cell manufacturing technique ready for Phase I clinical trials
- Are we moving towards a more automated CAR-T cell manufacturing process?
Today's daily update
What were the highlights from today at #ASGCT19? @FreyaFSG is joined by David Schaffer, outgoing @ASGCTherapy Secretary, to look back on day 2 of the conference! #celltherapy #genetherapy pic.twitter.com/dfDIYkKxBm— RegMedNet (@RegMedNet) April 30, 2019
Tomorrow's agenda highlight
- Pathways Facilitating Access to Investigational Products: Past to Present (RTT) (Wednesday, May 01, 9am) with Jerry R. Mendell (The Research Institute at Nationwide Children's Hospital; OH, USA)